Michihiro Hidaka

2.9k total citations
88 papers, 1.7k citations indexed

About

Michihiro Hidaka is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Michihiro Hidaka has authored 88 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 36 papers in Immunology and 18 papers in Oncology. Recurrent topics in Michihiro Hidaka's work include Hematopoietic Stem Cell Transplantation (32 papers), Acute Myeloid Leukemia Research (21 papers) and T-cell and Retrovirus Studies (16 papers). Michihiro Hidaka is often cited by papers focused on Hematopoietic Stem Cell Transplantation (32 papers), Acute Myeloid Leukemia Research (21 papers) and T-cell and Retrovirus Studies (16 papers). Michihiro Hidaka collaborates with scholars based in Japan, United States and Canada. Michihiro Hidaka's co-authors include William L. Stanford, Alan Bernstein, Tetsuya Eto, Takahiro Fukuda, Naokuni Uike, Atae Utsunomiya, Koichi Miyamura, Shuichi Taniguchi, Kentaro Horikawa and Yoshiko Atsuta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Michihiro Hidaka

87 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michihiro Hidaka Japan 25 732 658 393 284 268 88 1.7k
Tadafumi Iino Japan 17 576 0.8× 566 0.9× 638 1.6× 290 1.0× 307 1.1× 39 1.5k
Hitoshi Suzushima Japan 19 1.0k 1.4× 571 0.9× 561 1.4× 369 1.3× 241 0.9× 57 1.9k
Aiko Sato‐Otsubo Japan 20 352 0.5× 494 0.8× 860 2.2× 188 0.7× 231 0.9× 40 1.6k
F Sigaux France 23 634 0.9× 697 1.1× 515 1.3× 380 1.3× 389 1.5× 43 1.7k
Noriaki Yoshida Japan 20 450 0.6× 295 0.4× 256 0.7× 372 1.3× 130 0.5× 65 1.2k
Youmna Kfoury United States 25 1.0k 1.4× 620 0.9× 980 2.5× 537 1.9× 510 1.9× 42 2.5k
I Miyoshi Japan 17 283 0.4× 594 0.9× 1.2k 3.2× 643 2.3× 153 0.6× 77 2.1k
E Tatsumi Japan 21 685 0.9× 313 0.5× 639 1.6× 612 2.2× 287 1.1× 82 1.8k
Miller Cw United States 28 497 0.7× 295 0.4× 1.3k 3.3× 1.2k 4.1× 159 0.6× 59 2.5k
Vahid Asnafi France 28 719 1.0× 986 1.5× 784 2.0× 461 1.6× 304 1.1× 109 2.7k

Countries citing papers authored by Michihiro Hidaka

Since Specialization
Citations

This map shows the geographic impact of Michihiro Hidaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michihiro Hidaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michihiro Hidaka more than expected).

Fields of papers citing papers by Michihiro Hidaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michihiro Hidaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michihiro Hidaka. The network helps show where Michihiro Hidaka may publish in the future.

Co-authorship network of co-authors of Michihiro Hidaka

This figure shows the co-authorship network connecting the top 25 collaborators of Michihiro Hidaka. A scholar is included among the top collaborators of Michihiro Hidaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michihiro Hidaka. Michihiro Hidaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shimizu, Kanako, Tomonori Iyoda, Hiroshi Nakazato, et al.. (2021). Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2. Communications Biology. 4(1). 1365–1365. 21 indexed citations
3.
4.
Suzuki, Yasuhiro, Takahiro Yano, Youko Suehiro, et al.. (2018). Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults. International Journal of Hematology. 108(2). 161–166. 5 indexed citations
5.
Fuji, Shigeo, Saiko Kurosawa, Yoshihiro Inamoto, et al.. (2018). Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis. Bone Marrow Transplantation. 53(7). 905–908. 17 indexed citations
6.
7.
Fujiwara, Hiroshi, Shigeo Fuji, Atsushi Wake, et al.. (2017). Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study. Bone Marrow Transplantation. 52(3). 484–488. 15 indexed citations
8.
Tokunaga, Kenji, Shikiko Ueno, Yoshitaka Kikukawa, et al.. (2017). Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/<i>RUNX1-RUNX1T1</i> Rearrangement. Internal Medicine. 57(4). 563–568. 6 indexed citations
9.
Yamamoto, Chihiro, Hiroyasu Ogawa, Takahiro Fukuda, et al.. (2017). Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(4). 708–716. 9 indexed citations
10.
Miyamoto, Toshihiro, Tomoaki Fujisaki, Naoyuki Uchida, et al.. (2017). Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission. International Journal of Hematology. 107(4). 468–477. 13 indexed citations
11.
Nakane, Takahiko, Hirohisa Nakamae, Takuhiro Yamaguchi, et al.. (2016). Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials. International Journal of Hematology. 105(4). 485–496. 5 indexed citations
12.
Fuji, Shigeo, Hiroshi Fujiwara, Nobuaki Nakano, et al.. (2015). Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma. Bone Marrow Transplantation. 51(2). 205–211. 39 indexed citations
13.
14.
Hatanaka, Kazuo, Shigeo Fuji, Kazuhiro Ikegame, et al.. (2012). Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin. International Journal of Hematology. 96(6). 773–780. 9 indexed citations
15.
Shimizu, Kanako, Michihiro Hidaka, Kara Bickham, et al.. (2010). Human leukemic cells loaded with α-galactosylceramide (α-GalCer) activate murine NKT cells in situ. International Journal of Hematology. 92(1). 152–160. 6 indexed citations
16.
Teshima, Takanori, Koji Nagafuji, Hideho Henzan, et al.. (2009). Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease. International Journal of Hematology. 90(2). 253–260. 39 indexed citations
17.
Tanosaki, Ryuji, Naokuni Uike, Atae Utsunomiya, et al.. (2008). Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome. Biology of Blood and Marrow Transplantation. 14(6). 702–708. 43 indexed citations
18.
Shimizu, Kanako, Michihiro Hidaka, Norimitsu Kadowaki, et al.. (2006). Evaluation of the Function of Human Invariant NKT Cells from Cancer Patients Using α-Galactosylceramide-Loaded Murine Dendritic Cells. The Journal of Immunology. 177(5). 3484–3492. 29 indexed citations
19.
Hamaki, Tamae, Masahiro Kami, Yoshinobu Kanda, et al.. (2005). Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients. Bone Marrow Transplantation. 35(6). 549–556. 40 indexed citations
20.
Kagimoto, Tadashi, Hiroyuki Hata, Michihiro Hidaka, et al.. (1997). Differential glycosylation of Bence Jones protein and kidney impairment in patients with plasma cell dyscrasia. Journal of Laboratory and Clinical Medicine. 129(2). 217–223. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadafumi Iino Breakdown of academic impact, for papers by Hitoshi Suzushima Breakdown of academic impact, for papers by Aiko Sato‐Otsubo Breakdown of academic impact, for papers by F Sigaux Breakdown of academic impact, for papers by Noriaki Yoshida Breakdown of academic impact, for papers by Youmna Kfoury Breakdown of academic impact, for papers by I Miyoshi Breakdown of academic impact, for papers by E Tatsumi Breakdown of academic impact, for papers by Miller Cw Breakdown of academic impact, for papers by Vahid Asnafi
Rankless by CCL
2026